Despite the prominent clinicopathological features of psoriasis, including a shortened cell cycle and hyperproliferation of keratinocytes, research has focused predominantly on the role of tumor necrosis factor-α (TNF-α) and the IL-23/IL-17A axis in driving disease pathogenesis [12]. Here, IL17A is linked to psoriasis.